Clinical Trials Logo

Parkinson's Disease clinical trials

View clinical trials related to Parkinson's Disease.

Filter by:

NCT ID: NCT02271503 Completed - Parkinson's Disease Clinical Trials

A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease

Start date: November 2015
Phase: Phase 2
Study type: Interventional

This is a randomized, open-label, rater-blinded, multicenter, 3-treatment, 3 period, single-dose crossover study. Approximately 51 qualified immediate-release (IR) CD-LD-experienced advanced Parkinson's disease patients will be randomized to 1 of 3 dosing sequences. Objectives: - Assess the pharmacodynamics and pharmacokinetics (PK) of IPX203 (carbidopa and levodopa) in subjects with advanced Parkinson's disease. - Characterize the safety of IPX203 in subjects with advanced Parkinson's disease.

NCT ID: NCT02267785 Active, not recruiting - Parkinson's Disease Clinical Trials

Exercise Targeting Cognitive Impairment in Parkinson's Disease

Start date: October 2014
Phase: N/A
Study type: Interventional

The aim of this application is to compare and elucidate the effects of skill-based versus aerobic exercise versus control on mild cognitive impairment (MCI) of the executive function (EF) subtype in Parkinson's disease (PD); we hypothesize that skill-based exercise will result in the greatest improvement in EF and lead to modification of underlying neural substrates.

NCT ID: NCT02266004 Terminated - Parkinson's Disease Clinical Trials

Transcranial Direct Current Stimulation for Freezing of Gait

TDCS-FOG
Start date: September 12, 2014
Phase: N/A
Study type: Interventional

This study will evaluate the effects of transcranial direct current stimulation (tDCS) in combination with locomotor training in patients with Parkinson's disease (PD) and freezing of gait (FOG).

NCT ID: NCT02263885 Completed - Parkinson's Disease Clinical Trials

ExAblate Transcranial MRgFUS of the Globus Pallidum for Treatment of Parkinson's Disease

Start date: April 2015
Phase: N/A
Study type: Interventional

The proposed study will evaluate the safety, and initial efficacy of using the ExAblate Transcranial to create a unilateral lesion in the globus pallidus as an adjunct to PD medications in subjects who are over 30 years of age and considered medication-refractory with advanced idiopathic Parkinson's disease (PD).

NCT ID: NCT02256319 Completed - Parkinson's Disease Clinical Trials

Dexmedetomidine vs Propofol on the Recordings of Deep Brain Activity Measured Through Implanted Stimulators

DEXPROPAR
Start date: September 2014
Phase: Phase 4
Study type: Interventional

This clinical trial has been designed to study and compare changes in deep brain activity (field potentials) in Parkinson's disease (PD) patients while awake, and during sedation with dexmedetomidine or propofol. The recording is made through a deep brain stimulation (DBS) electrode implanted for PD management. The investigators hypothesize that dexmedetomidine produces fewer changes as compared to propofol, and that those changes are consistent and recognizable when compared to activity in patients not exposed to any sedation. Typification of those changes would in the future allow for patients to undergo this surgery comfortably while not compromising the quality of the recording and of the final clinical outcome. The principal variable analyzed is the signal's power in each of the frequency bands, absolute and relative. The analysis will include usual clinical methods such as rapid Fourier transform (FFT) and window fast Fourier transform (WFFT), wavelet analysis, Gabor, and coherence.

NCT ID: NCT02253563 Completed - Parkinson's Disease Clinical Trials

Resistance Versus Balance Training in Parkinson's Disease

Start date: June 2011
Phase: N/A
Study type: Interventional

Comparison of resistance training versus balance training to improve postural control in patients with Parkinson's Disease

NCT ID: NCT02252380 Active, not recruiting - Parkinson's Disease Clinical Trials

ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders

Start date: May 2015
Phase: N/A
Study type: Interventional

The proposed study is to evaluate the effectiveness of ExAblate Transcranial MRgFUS as a tool for creating a unilateral lesion in the Vim thalamus or the globus pallidus (GPi) in patients with treatment-refractory symptoms of movement disorders.

NCT ID: NCT02251808 Recruiting - Parkinson's Disease Clinical Trials

Satisfaction Survey on PINS Stimulator System for Patients With Parkinson's Disease

Start date: September 2014
Phase: N/A
Study type: Observational

This study will be done because the investigators would like to evaluate product satisfaction of two PINS products (product A, product B) that are to evaluate the effectiveness of rechargeable and non-rechargeable Deep Brain Stimulation (at baseline visit and at follow-up visit) and by evaluating their responses to the product satisfaction survey that will be given to them by a study coordinator.

NCT ID: NCT02248649 Completed - Parkinson's Disease Clinical Trials

Telemedicine Intervention to Improve Cognitive Function

Start date: December 1, 2014
Phase: N/A
Study type: Interventional

This project is investigating whether a home-based exercise program will reduce cognitive decline in patients with Parkinson's disease.

NCT ID: NCT02246374 Active, not recruiting - Parkinson's Disease Clinical Trials

ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease

Start date: September 2014
Phase: N/A
Study type: Interventional

This is primarily a safety protocol to evaluate the safety of subthalamotomy using Transcranial ExAblate for treatment of Parkinson's Disease (PD) motor features.